Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-23-036248

EVP & Chief Commercial Officer sold 1,839 shares at $2.35 ($4,322)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Cheng Sohanya Roshan · EVP & Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-06-08 Sale : show line 1 in the form 10b5-1 −1,839 $2.35 $4,322 211,501 D
Open-market sales · 1,839 sh · avg $2.35 · $4,322
Loading xslF345X04/doc4.xml…